Home Cart 0 Sign in  

[ CAS No. 88770-19-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 88770-19-8
Chemical Structure| 88770-19-8
Structure of 88770-19-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 88770-19-8 ]

Related Doc. of [ 88770-19-8 ]

Alternatived Products of [ 88770-19-8 ]

Product Details of [ 88770-19-8 ]

CAS No. :88770-19-8 MDL No. :MFCD13386488
Formula : C6H5BrO2S Boiling Point : -
Linear Structure Formula :- InChI Key :VFWZOBQPAHYSDL-UHFFFAOYSA-N
M.W : 221.07 Pubchem ID :45873035
Synonyms :

Calculated chemistry of [ 88770-19-8 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.17
Num. rotatable bonds : 2
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 43.3
TPSA : 54.54 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.89 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.29
Log Po/w (XLOGP3) : 2.48
Log Po/w (WLOGP) : 2.3
Log Po/w (MLOGP) : 1.69
Log Po/w (SILICOS-IT) : 3.04
Consensus Log Po/w : 2.36

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.01
Solubility : 0.216 mg/ml ; 0.000975 mol/l
Class : Soluble
Log S (Ali) : -3.27
Solubility : 0.119 mg/ml ; 0.000537 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.6
Solubility : 0.553 mg/ml ; 0.0025 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.57

Safety of [ 88770-19-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 88770-19-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 88770-19-8 ]
  • Downstream synthetic route of [ 88770-19-8 ]

[ 88770-19-8 ] Synthesis Path-Upstream   1~6

  • 1
  • [ 89280-91-1 ]
  • [ 76360-43-5 ]
  • [ 88770-19-8 ]
Reference: [1] Journal of Materials Chemistry, 1999, vol. 9, # 9, p. 2155 - 2163
  • 2
  • [ 67-56-1 ]
  • [ 100523-84-0 ]
  • [ 88770-19-8 ]
YieldReaction ConditionsOperation in experiment
91%
Stage #1: for 12 h; Reflux
Stage #2: With sodium hydrogencarbonate In water
A solution of bromine (2 mL, 39.06 mmol) in glacial acetic acid (64 mL) was added slowly to a stirred solution of Int-1 (5 g, 39.06 mmol) in glacial acetic acid (37 mL) at 0° C. and stirred at room temperature for 20 minutes. The reaction mixture was then poured into ice water while stirring vigorously. The white precipitated solid was filtered, washed with water and recrystallised from hot water to afford pure Int-2 as white solid (3.68 g, 46percent). 1H NMR (200 MHz, dmso-d6): δ 7.55 (s, 1H), 8.17 (s, 1H). To a stirred solution of Int-2 (3.4 g, 16.42 mmol) in methanol (40 mL) was added H2SO4 (321 mg, 3.28 mmol) and stirred under reflux for 12 hours. Volatiles from the reaction mixture were distilled off under reduced pressure and the resulting residue was extracted with DCM (75 mL). The organic extract was washed with water (40 mL), saturated aqueous NaHCO3 solution (40 mL), brine (40 mL) and dried over Na2SO4, filtered and concentrated under vacuum to afford pure Int-3 as colorless viscous oil (3.3 g, 91percent). 1H NMR (200 MHz, dmso-d6): δ 7.98 (s, 1H), 7.44 (s, 1H), 3.87 (s, 3H). To a stirred solution of Int-3 (0.5 g, 2.26 mmol) in dioxane (25 mL) was added Int-4 (0.51 g, 2.26 mmol) followed by Pd (OAc) 2 (105 mg, 0.45 mmol), xanthpos (265 mg, 0.497 mmol) and CS2CO3 (1.18 g, 3.62 mmol). The reaction mixture was degassed under vacuum, bubbled with N2 for 10 minutes and stirred under reflux for 20 hours. The reaction mixture was concentrated under reduced pressure and was purified by column chromatography to isolate product and a very close spot together eluting with EtOAc. This mixture (140 mg) was further purified with preparative HPLC to obtain pure Int-5 as a yellow solid (80 mg, 10percent). Mass (m/z): 366.0 [M++1]. 1H NMR (200 MHz, dmso-d6): 9.50 (d, J=7 Hz, 1H), 8.51 (d, J=7 Hz, 1H), 8.56 (d, J=5.2 Hz, 1H), 7.74 (brs, 1H), 7.66 (d, J=11.8 Hz, 1H), 7.35 (d, J=7.4 Hz, 1H), 7.11 (s, 1H), 7.02 (d, J=5.6 Hz, 1H), 6.87 (t, J=6.8 Hz, 1H), 3.86 (s, 3H), 2.73 (s, 3H). To a stirred solution of Int-5 (0.7 g, 1.91 mmol) in THF: MeOH: H2O (2:1:2) (50 ml) was added LiOH (0.24 g, 5.74 mmol) at room temperature and stirred while heating at 50° C. for 16 hours. Volatiles from the reaction mixture were distilled off under reduced pressure, the reaction mixture was acidified to about pH 5-6 with 2N HCl. The precipitated solid was filtered and dried under vacuum to afford pure Int-6 (0.51 g, 76percent). Mass (m/z): 352.0 [M++1]. 1H NMR (200 MHz, dmso-d6): δ 12.45 (brs, 1H), 10.87 (s, 1H), 9.70 ((brs, 1H), 8.60 (d, J=4.68 Hz, 1H), 7.67-7.59 (m, 2H), 7.45 (t, J=8.4 Hz, 1H), 7.13 (d, J=5.2 Hz, 1H), 7.04 (s, 2H), 2.65 (s, 3H).
Reference: [1] Patent: US2010/29638, 2010, A1, . Location in patent: Page/Page column 110
[2] Tetrahedron Letters, 2013, vol. 54, # 11, p. 1460 - 1462
[3] Journal of Materials Chemistry C, 2018, vol. 6, # 14, p. 3731 - 3742
[4] Patent: WO2005/9941, 2005, A1, . Location in patent: Page 43-44
[5] Patent: WO2011/33255, 2011, A1, . Location in patent: Page/Page column 72
  • 3
  • [ 89280-91-1 ]
  • [ 76360-43-5 ]
  • [ 88770-19-8 ]
Reference: [1] Journal of Materials Chemistry, 1999, vol. 9, # 9, p. 2155 - 2163
  • 4
  • [ 88-13-1 ]
  • [ 88770-19-8 ]
Reference: [1] Patent: WO2011/33255, 2011, A1,
[2] Tetrahedron Letters, 2013, vol. 54, # 11, p. 1460 - 1462
[3] Journal of Materials Chemistry C, 2018, vol. 6, # 14, p. 3731 - 3742
  • 5
  • [ 100523-84-0 ]
  • [ 88770-19-8 ]
Reference: [1] Archiv der Pharmazie, 1998, vol. 331, # 12, p. 405 - 411
  • 6
  • [ 67-56-1 ]
  • [ 98215-44-2 ]
  • [ 88770-19-8 ]
Reference: [1] Archiv der Pharmazie, 1998, vol. 331, # 12, p. 405 - 411
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 88770-19-8 ]

Bromides

Chemical Structure| 170355-38-1

[ 170355-38-1 ]

Ethyl 5-bromothiophene-3-carboxylate

Similarity: 0.96

Chemical Structure| 89280-91-1

[ 89280-91-1 ]

Methyl 2,5-dibromothiophene-3-carboxylate

Similarity: 0.95

Chemical Structure| 76360-43-5

[ 76360-43-5 ]

Methyl 2-bromothiophene-3-carboxylate

Similarity: 0.95

Chemical Structure| 289470-44-6

[ 289470-44-6 ]

Ethyl 2,5-dibromothiophene-3-carboxylate

Similarity: 0.92

Chemical Structure| 632325-50-9

[ 632325-50-9 ]

Ethyl 2-bromothiophene-3-carboxylate

Similarity: 0.92

Esters

Chemical Structure| 170355-38-1

[ 170355-38-1 ]

Ethyl 5-bromothiophene-3-carboxylate

Similarity: 0.96

Chemical Structure| 89280-91-1

[ 89280-91-1 ]

Methyl 2,5-dibromothiophene-3-carboxylate

Similarity: 0.95

Chemical Structure| 76360-43-5

[ 76360-43-5 ]

Methyl 2-bromothiophene-3-carboxylate

Similarity: 0.95

Chemical Structure| 289470-44-6

[ 289470-44-6 ]

Ethyl 2,5-dibromothiophene-3-carboxylate

Similarity: 0.92

Chemical Structure| 632325-50-9

[ 632325-50-9 ]

Ethyl 2-bromothiophene-3-carboxylate

Similarity: 0.92